Speaker illustration

Doctor Raj Makkar

Cedars-Sinai Medical Center, Los Angeles (United States of America)

I began my interventional career 25 years ago firmly believing that solutions to heart diseases in the Catheterization Lab needed to come from a combination of mechanical and biologic tools. While my earlier focus was on stent thrombosis and restenosis, over the last 11 years, I have developed a special interest in transcatheter aortic valve replacement. To date, I have performed close to 3000 TAVR procedures with excellent clinical outcomes. In addition to a high volume of cases, I have contributed extensively to the literature, participating in numerous multicenter clinical trials of TAVR. Notably, I have been involved in every PARTNER trial to date and am cumulatively the highest enroller in the PARTNER series. This contribution has been reflected in authorship of numerous manuscripts in high-ranking peer-reviewed journals, including six New England Journal of Medicine publications. Most recently, I have developed a further interest in leaflet motion abnormalities in TAVR patients.

Outcomes after TAVI in bicuspid aortic valves.

Event: ESC Congress 2021 - The Digital Experience

Topic: Valvular Heart Disease

Session: TAVI in bicuspid aortic valves: a challenge

Thumbnail

An asymptomatic patient with severe aortic stenosis - How I did treat

Event: ESC Congress 2019

Topic: Aortic Valve Stenosis

Session: How should I treat challenging patients with severe aortic stenosis?

Thumbnail

An asymptomatic patient with severe aortic stenosis - Case presentation

Event: ESC Congress 2019

Topic: Aortic Valve Stenosis

Session: How should I treat challenging patients with severe aortic stenosis?

Thumbnail

Pure aortic regurgitation remains off-limits for TAVI - CON

Event: ESC Congress 2019

Topic: Treatment

Session: Controversies in the treatment of aortic valve disease

Thumbnail

Managing TAVI complications.

Event: ESC Congress 2019

Topic: Noncoronary Cardiac Intervention

Session: TAVI - Tips and tricks for beginners

Thumbnail

TAVI leaflet thrombosis – Current data and implications for clinical practice

Event: ESC Congress 2018

Topic: Treatment

Session: The Future of TAVI-Perspectives from both sides of the Atlantic

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb